UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
(Exact name of registrant as specified in charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area
code:
(Former Name and Former Address)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by
checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.02 Unregistered Sales of Equity Securities.
On July 7, 2026, Zapata Quantum, Inc. (the “Company”) issued a press release announcing that Sumit Kapur, the Company’s Chief Executive Officer, will present at the Global Technology Virtual Investor Conference on Thursday, July 9, 2026 at 10:30 a.m. Eastern Time A copy of the press release is furnished as Exhibit 99.1 of this Current Report on Form 8-K.
The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Incorporated by Reference | Filed or Furnished | |||||||||
| Exhibit # | Exhibit Description | Form | Date | Number | Herewith | |||||
| 99.1 | Press Release dated July 7, 2026 | Furnished | ||||||||
| 104 | Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101) | |||||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 7, 2026
| ZAPATA QUANTUM, INC. | ||
| By: | /s/ Sumit Kapur | |
| Sumit Kapur, Chief Executive Officer | ||
Exhibit 99.1
Zapata Quantum to Present at the Global Technology Virtual Investor Conference July 9th
CEO Sumit Kapur will discuss highlights including the Company's NVIDIA collaboration and quantum cancer research recognized as a Nature Biotechnology Top 10
BOSTON, Massachusetts – July 7, 2026 – Zapata Quantum (OTCQB: ZPTA) (“Zapata” or the “Company”) today announced that its CEO, Sumit Kapur, will present live at the Global Technology Virtual Investor Conference hosted by Virtual Investor Conferences and OTC Markets this Thursday, July 9, 2026.
Date: July 9
Time: 10:30 a.m. ET
Link: Zapata Quantum’s Presentation
Kapur will be available for one-on-one meetings on July 10 from 10 a.m. to 12 p.m. ET, and July 14 from 11 a.m. to 1 p.m. ET. Scheduling is available through this link.
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are unable to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
| · | Collaboration with NVIDIA to apply agentic AI to accelerate quantum algorithm development: The initiative targets the creation of a scalable automated system for quantum resource estimation, a major bottleneck in quantum application development. | |
| · | Groundbreaking quantum-enabled drug discovery research recognized as one of the Top 10 Papers of 2025 by Nature Biotechnology: The study, co-authored with Dana-Farber Cancer Institute, University of Toronto, and Insilico Medicine, provides a proof point of Zapata’s capabilities and quantum computing’s transformative potential to generate viable drug candidates in the biotech domain. | |
| · | Successful restructuring capped by $15 million fundraise led by Triatomic Capital: The Company has also expanded its leadership team with quantum software pioneers including Yudong Cao, former Head of Quantum at BCG X, as CTO. |
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
| 1 |
About Zapata Quantum
Zapata Quantum is a leading hardware-agnostic, pure-play quantum software company focused on accelerating quantum application development. With a portfolio of more than 60 granted and pending patents developed over seven years, Zapata supports applications across cryptography, pharmaceuticals, finance, materials discovery, defense, and more. The Company is the only organization to have participated across all technical areas of DARPA’s Quantum Benchmarking program and has worked with Fortune 500 enterprises and government agencies to translate quantum advances into real-world impact. The Company’s study demonstrating the potential of quantum-enabled drug discovery was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025. For more information, visit ZapataQuantum.com.
CONTACTS:
HKA Marketing Communications
Taylor White
Account Manager
(714) 426-0444
taylor@hkamarcom.com
Virtual Investor Conferences
Greg Young
VP Corporate Services
OTC Markets Group
(212) 652-5958
greg@otcmarkets.com
| 2 |